The customer observed a false non-reactive architect hiv ag/ab result generated on a 28-year-old pregnant female patient sample.The following data was provided (reference range <1.00 is non-reactive): colloidal gold initial = positive, then tested on the architect and result = 0.23 s/co, sample centrifuged and retested.Result = non-reactive.Repeat colloidal gold = positive, and negative.No impact to patient management was reported.
|
The complaint investigation included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, device history record review, and in-house testing of a retained reagent kit.Return testing was not completed as returns were not available.A review of tracking and trending did not identify any trends for the issue for the product.Device history record review for lot 54530be00 did not identify any non-conformances or deviations with the complaint lot.Data and information provided by the customer were reviewed and support the complaint issue without indication for any additional issue.In-house testing of a retained reagent kit of the complaint lot was performed.All specifications were met, and no false reactive results were obtained, indicating that the lot generates the expected results.In addition, the clinical sensitivity of the lot was evaluated by testing two commercially available seroconversion panels.The lot detected the same bleeds as reactive for the seroconversion panels, which indicates the sensitivity performance of the complaint lot is not negatively affected.Labeling was reviewed and sufficiently addresses the customer's issue.Based on the investigation, no systemic issue or deficiency with the architect hiv ag/ab reagent lot number 54530be00, was identified.
|
The customer observed a false non-reactive architect hiv ag/ab result generated on a 28-year-old pregnant female patient sample.The following data was provided (reference range <1.00 is non-reactive): colloidal gold initial = positive, then tested on the architect and result = 0.23 s/co, sample centrifuged and retested.Result = non-reactive.Repeat colloidal gold = positive, and negative.No impact to patient management was reported.
|